Elevate Your Investing Strategy:<\/p>\n
Myriad Genetics ( (MYGN)<\/a> ) has shared an announcement.<\/p>\n On September 29, 2025, Myriad Genetics<\/a> announced the resignation of Natalie Munk, their Senior Vice President and Chief Accounting Officer, effective October 24, 2025. Her departure was not due to any disagreements with the company. In response, the company appointed Benjamin R. Wheeler, their current Chief Financial Officer, as the new principal accounting officer effective upon Munk\u2019s departure. Wheeler, who has been with the company for over thirteen years in various financial roles, will not receive additional compensation for this new designation.<\/p>\n The most recent analyst rating on (MYGN)<\/a> stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Myriad Genetics stock, see the MYGN Stock Forecast page<\/a>.<\/p>\n Spark\u2019s Take on MYGN Stock<\/b><\/p>\n According to Spark, TipRanks\u2019 AI<\/a> Analyst, MYGN is a Neutral.<\/p>\n Myriad Genetics\u2019 overall stock score reflects strong revenue growth and positive earnings call sentiment. However, significant challenges in profitability, cash flow management, and valuation weigh heavily on the score. The technical analysis shows short-term strength, but longer-term indicators suggest caution.<\/p>\n To see Spark\u2019s full report on MYGN stock, click here<\/a>. <\/p>\n More about Myriad Genetics<\/b><\/p>\n Average Trading Volume:<\/b> 1,743,013<\/p>\n Technical Sentiment Signal:<\/b> Sell<\/p>\n Current Market Cap:<\/b> $703.4M<\/p>\n For an in-depth examination of MYGN stock, go to TipRanks\u2019 Overview page<\/a>.<\/p>\n Disclaimer & Disclosure<\/a>Report an Issue<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data,…\n","protected":false},"author":3,"featured_media":275558,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[815,159,67,132,68],"class_list":{"0":"post-275557","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-genetics","9":"tag-science","10":"tag-united-states","11":"tag-unitedstates","12":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115312408825950192","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/275557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=275557"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/275557\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/275558"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=275557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=275557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=275557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}